Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Pizotifen Tablet bulk supplier for pharma manufacturers

Pizotifen Tablet 0.5 mg, 1.5 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 0.5 mg, 1.5 mg

Reference Brands: Mosegor (EU), Sandomigran (EU)

Category: Neurology

Pizotifen is a serotonin (5-HT2) receptor antagonist with antihistamine properties used for the prevention of migraine and cluster headaches. It helps reduce the frequency and severity of migraine attacks but is not intended for acute treatment. Available mainly as 0.5 mg and 1.5 mg oral tablets, it works by blocking serotonin activity in the brain to prevent blood vessel changes that trigger headaches.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Pizotifen Tablet — third party manufacturing & bulk supply

Pizotifen Tablet 0.5 mg, 1.5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Pizotifen Tablet is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Pizotifen Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Pizotifen Tablet →
Back to Listing

Frequently Asked Questions

Pizotifen Tablet is listed as Tablets in 0.5 mg, 1.5 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Pizotifen Tablet is referenced against Mosegor (EU), Sandomigran (EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Valproic Acid

Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL

Form: Tablet / Capsule/ Injection / Oral syrup

Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)

View Details
Ubrogepant

Strength:
50 mg, 100 mg

Form: Tablets

Reference Brands: Ubrelvy (USA/India)

View Details
Tolcapone

Strength:
100 mg

Form: Tablets

Reference Brands: Tasmar (USA/EU)

View Details
Safinamide

Strength:
50 mg ,100 mg

Form: Tablets

Reference Brands: Xadago (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.